The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mitral Valve Device Market Research Report 2024
Synopsis
Mitral valve products primarily include the TMVCRS, the TMVr-A system, and the TMVr-F system.
Global Mitral Valve Device market is projected to reach US$ 5193.8 million in 2029, increasing from US$ 957 million in 2022, with the CAGR of 27.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mitral Valve Device market research.
The valvular disease interventional device market is driven by the increasing prevalence of valvular heart diseases and the growing demand for less invasive and effective treatment options. Valvular disease interventional devices are medical devices used to repair or replace damaged heart valves through minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR) or mitral valve repair. The rise in the aging population and the incidence of valvular diseases contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of innovative devices have improved the outcomes and safety of valvular disease treatments. However, the market also faces challenges, including the high cost of some interventional devices and the need for skilled healthcare professionals trained in interventional cardiology. Additionally, addressing reimbursement issues and ensuring the long-term durability of interventional devices can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer advanced valvular disease interventional devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for less invasive and effective solutions for valvular heart diseases.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Mitral Valve Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
Valcare Medical Ltd
Mitralign, Inc.
Segment by Type
TMVr-A
TMVr-F
Segment by Application
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Mitral Valve Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Mitral valve products primarily include the TMVCRS, the TMVr-A system, and the TMVr-F system.
Global Mitral Valve Device market is projected to reach US$ 5193.8 million in 2029, increasing from US$ 957 million in 2022, with the CAGR of 27.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mitral Valve Device market research.
The valvular disease interventional device market is driven by the increasing prevalence of valvular heart diseases and the growing demand for less invasive and effective treatment options. Valvular disease interventional devices are medical devices used to repair or replace damaged heart valves through minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR) or mitral valve repair. The rise in the aging population and the incidence of valvular diseases contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of innovative devices have improved the outcomes and safety of valvular disease treatments. However, the market also faces challenges, including the high cost of some interventional devices and the need for skilled healthcare professionals trained in interventional cardiology. Additionally, addressing reimbursement issues and ensuring the long-term durability of interventional devices can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer advanced valvular disease interventional devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for less invasive and effective solutions for valvular heart diseases.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Mitral Valve Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
Valcare Medical Ltd
Mitralign, Inc.
Segment by Type
TMVr-A
TMVr-F
Segment by Application
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Mitral Valve Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Mitral Valve Device Market Overview
1.1 Product Overview and Scope of Mitral Valve Device
1.2 Mitral Valve Device Segment by Type
1.2.1 Global Mitral Valve Device Market Value Comparison by Type (2023-2029)
1.2.2 TMVr-A
1.2.3 TMVr-F
1.3 Mitral Valve Device Segment by Application
1.3.1 Global Mitral Valve Device Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Cardiac Catheterization Laboratory
1.4 Global Mitral Valve Device Market Size Estimates and Forecasts
1.4.1 Global Mitral Valve Device Revenue 2018-2029
1.4.2 Global Mitral Valve Device Sales 2018-2029
1.4.3 Global Mitral Valve Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Mitral Valve Device Market Competition by Manufacturers
2.1 Global Mitral Valve Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Mitral Valve Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Mitral Valve Device Average Price by Manufacturers (2018-2023)
2.4 Global Mitral Valve Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Mitral Valve Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mitral Valve Device, Product Type & Application
2.7 Mitral Valve Device Market Competitive Situation and Trends
2.7.1 Mitral Valve Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mitral Valve Device Players Market Share by Revenue
2.7.3 Global Mitral Valve Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mitral Valve Device Retrospective Market Scenario by Region
3.1 Global Mitral Valve Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Mitral Valve Device Global Mitral Valve Device Sales by Region: 2018-2029
3.2.1 Global Mitral Valve Device Sales by Region: 2018-2023
3.2.2 Global Mitral Valve Device Sales by Region: 2024-2029
3.3 Global Mitral Valve Device Global Mitral Valve Device Revenue by Region: 2018-2029
3.3.1 Global Mitral Valve Device Revenue by Region: 2018-2023
3.3.2 Global Mitral Valve Device Revenue by Region: 2024-2029
3.4 North America Mitral Valve Device Market Facts & Figures by Country
3.4.1 North America Mitral Valve Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Mitral Valve Device Sales by Country (2018-2029)
3.4.3 North America Mitral Valve Device Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mitral Valve Device Market Facts & Figures by Country
3.5.1 Europe Mitral Valve Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Mitral Valve Device Sales by Country (2018-2029)
3.5.3 Europe Mitral Valve Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mitral Valve Device Market Facts & Figures by Country
3.6.1 Asia Pacific Mitral Valve Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Mitral Valve Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Mitral Valve Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mitral Valve Device Market Facts & Figures by Country
3.7.1 Latin America Mitral Valve Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Mitral Valve Device Sales by Country (2018-2029)
3.7.3 Latin America Mitral Valve Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mitral Valve Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Mitral Valve Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Mitral Valve Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Mitral Valve Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mitral Valve Device Sales by Type (2018-2029)
4.1.1 Global Mitral Valve Device Sales by Type (2018-2023)
4.1.2 Global Mitral Valve Device Sales by Type (2024-2029)
4.1.3 Global Mitral Valve Device Sales Market Share by Type (2018-2029)
4.2 Global Mitral Valve Device Revenue by Type (2018-2029)
4.2.1 Global Mitral Valve Device Revenue by Type (2018-2023)
4.2.2 Global Mitral Valve Device Revenue by Type (2024-2029)
4.2.3 Global Mitral Valve Device Revenue Market Share by Type (2018-2029)
4.3 Global Mitral Valve Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Mitral Valve Device Sales by Application (2018-2029)
5.1.1 Global Mitral Valve Device Sales by Application (2018-2023)
5.1.2 Global Mitral Valve Device Sales by Application (2024-2029)
5.1.3 Global Mitral Valve Device Sales Market Share by Application (2018-2029)
5.2 Global Mitral Valve Device Revenue by Application (2018-2029)
5.2.1 Global Mitral Valve Device Revenue by Application (2018-2023)
5.2.2 Global Mitral Valve Device Revenue by Application (2024-2029)
5.2.3 Global Mitral Valve Device Revenue Market Share by Application (2018-2029)
5.3 Global Mitral Valve Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Mitral Valve Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Mitral Valve Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Edwards Lifesciences
6.2.1 Edwards Lifesciences Corporation Information
6.2.2 Edwards Lifesciences Description and Business Overview
6.2.3 Edwards Lifesciences Mitral Valve Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Edwards Lifesciences Mitral Valve Device Product Portfolio
6.2.5 Edwards Lifesciences Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Mitral Valve Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Medtronic Mitral Valve Device Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Boston Scientific
6.4.1 Boston Scientific Corporation Information
6.4.2 Boston Scientific Description and Business Overview
6.4.3 Boston Scientific Mitral Valve Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boston Scientific Mitral Valve Device Product Portfolio
6.4.5 Boston Scientific Recent Developments/Updates
6.5 Valcare Medical Ltd
6.5.1 Valcare Medical Ltd Corporation Information
6.5.2 Valcare Medical Ltd Description and Business Overview
6.5.3 Valcare Medical Ltd Mitral Valve Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Valcare Medical Ltd Mitral Valve Device Product Portfolio
6.5.5 Valcare Medical Ltd Recent Developments/Updates
6.6 Mitralign, Inc.
6.6.1 Mitralign, Inc. Corporation Information
6.6.2 Mitralign, Inc. Description and Business Overview
6.6.3 Mitralign, Inc. Mitral Valve Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mitralign, Inc. Mitral Valve Device Product Portfolio
6.6.5 Mitralign, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mitral Valve Device Industry Chain Analysis
7.2 Mitral Valve Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mitral Valve Device Production Mode & Process
7.4 Mitral Valve Device Sales and Marketing
7.4.1 Mitral Valve Device Sales Channels
7.4.2 Mitral Valve Device Distributors
7.5 Mitral Valve Device Customers
8 Mitral Valve Device Market Dynamics
8.1 Mitral Valve Device Industry Trends
8.2 Mitral Valve Device Market Drivers
8.3 Mitral Valve Device Market Challenges
8.4 Mitral Valve Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
